Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-17-022038
Filing Date
2017-06-22
Accepted
2017-06-22 16:08:06
Documents
1
Period of Report
2017-06-21

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 10336
  Complete submission text file 0001127602-17-022038.txt   11734
Mailing Address 1040 SPRING ST SILVER SPRING MD 20910
Business Address 1040 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Issuer) CIK: 0001082554 (see all company filings)

EIN.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 7711 CARONDELET ST. LOUIS MO 63105
Business Address
Thompson Tommy G (Reporting) CIK: 0001324863 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26301 | Film No.: 17925163